Diverse Eastern and Western Approaches to the Management of Gastric Cancer

Por Ohtsu, Atsushi
Publicado em 2007

A Case of Descending Necrotizing MediastinitisPenetrating to the Esophagus

Por Inaba, Yuichiro, Tokano, Hisashi, Ohtsu, Atsushi, Kitamura, Ken
Publicado no J Rural Med (2010)

Phase I study of olaratumab in Japanese patients with advanced solid tumors

Por Doi, Toshihiko, Ma, Yan, Dontabhaktuni, Aruna, Nippgen, Cornelia, Nippgen, Johannes, Ohtsu, Atsushi
Publicado no Cancer Sci (2014)

Phase I Clinical and Pharmacokinetic Study of RAD001 (Everolimus) Administered Daily to Japanese Patients with Advanced Solid Tumors

Por Okamoto, Isamu, Doi, Toshihiko, Ohtsu, Atsushi, Miyazaki, Masaki, Tsuya, Asuka, Kurei, Katsutoshi, Kobayashi, Ken, Nakagawa, Kazuhiko
Publicado em 2010

Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma

Por Morimoto, Hiroyuki, Yano, Tomonori, Yoda, Yusuke, Oono, Yasuhiro, Ikematsu, Hiroaki, Hayashi, Ryuichi, Ohtsu, Atsushi, Kaneko, Kazuhiro
Publicado no World J Gastroenterol (2017)

Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors

Por Doi, Toshihiko, Ohtsu, Atsushi, Fuse, Nozomu, Yoshino, Takayuki, Tahara, Makoto, Shibayama, Kazuhiro, Takubo, Takatoshi, Weinreich, David M.
Publicado em 2012

Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer

Por Doi, Toshihiko, Yoshino, Takayuki, Fuse, Nozomu, Boku, Narikazu, Yamazaki, Kentaro, Koizumi, Wasaburo, Shimada, Ken, Takinishi, Yasutaka, Ohtsu, Atsushi
Publicado no Invest New Drugs (2015)

Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma

Por Hatogai, Ken, Fujii, Satoshi, Kojima, Takashi, Daiko, Hiroyuki, Doi, Toshihiko, Ohtsu, Atsushi, Ochiai, Atsushi, Takiguchi, Yuichi, Yoshino, Takayuki
Publicado no BMC Cancer (2017)

A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors

Por Doi, Toshihiko, Fuse, Nozomu, Yoshino, Takayuki, Kojima, Takashi, Bando, Hideaki, Miyamoto, Hideaki, Kaneko, Masato, Osada, Motonobu, Ohtsu, Atsushi
Publicado no Cancer Chemother Pharmacol (2016)

A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer

Por Yoshino, Takayuki, Yamazaki, Kentaro, Yamaguchi, Kensei, Doi, Toshihiko, Boku, Narikazu, Machida, Nozomu, Onozawa, Yusuke, Asayama, Masako, Fujino, Tadahiro, Ohtsu, Atsushi
Publicado em 2012

Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic...

Por Komatsu, Yoshito, Yoshino, Takayuki, Yamazaki, Kentaro, Yuki, Satoshi, Machida, Nozomu, Sasaki, Takahide, Hyodo, Ichinosuke, Yachi, Yutaka, Onuma, Hiroshi, Ohtsu, Atsushi
Publicado em 2013

Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors

Por Doi, Toshihiko, Onozawa, Yusuke, Fuse, Nozomu, Yoshino, Takayuki, Yamazaki, Kentaro, Watanabe, Junichiro, Akimov, Mikhail, Robson, Matthew, Boku, Narikazu, Ohtsu, Atsushi
Publicado em 2014

Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study

Por Kasi, Pashtoon M., Kotani, Daisuke, Cecchini, Michael, Shitara, Kohei, Ohtsu, Atsushi, Ramanathan, Ramesh K., Hochster, Howard S., Grothey, Axel, Yoshino, Takayuki
Publicado no BMC Cancer (2016)

NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysis

Por Doi, Toshihiko, Hamaguchi, Tetsuya, Shitara, Kohei, Iwasa, Satoru, Shimada, Yasuhiro, Harada, Mitsunori, Naito, Kenichiro, Hayashi, Naoto, Masada, Atsuhiro, Ohtsu, Atsushi
Publicado no Cancer Chemother Pharmacol (2017)

Phase 1 pharmacokinetic study of MK-0646 (dalotuzumab), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in combination with cetuximab and irinotecan in Japanese...

Por Doi, Toshihiko, Muro, Kei, Yoshino, Takayuki, Fuse, Nozomu, Ura, Takashi, Takahari, Daisuke, Feng, Hwa-ping, Shimamoto, Takashi, Noguchi, Kazuo, Ohtsu, Atsushi
Publicado em 2013

Phase 1 pharmacokinetic study of the oral pan-AKT inhibitor MK-2206 in Japanese patients with advanced solid tumors

Por Doi, Toshihiko, Tamura, Kenji, Tanabe, Yuko, Yonemori, Kan, Yoshino, Takayuki, Fuse, Nozomu, Kodaira, Makoto, Bando, Hideaki, Noguchi, Kazuo, Shimamoto, Takashi, Ohtsu, Atsushi
Publicado no Cancer Chemother Pharmacol (2015)

Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer

Por Hatogai, Ken, Yano, Tomonori, Kojima, Takashi, Onozawa, Masakatsu, Fujii, Satoshi, Daiko, Hiroyuki, Yoda, Yusuke, Hombu, Takuya, Doi, Toshihiko, Kaneko, Kazuhiro, Ohtsu, Atsushi
Publicado no Radiat Oncol (2016)

Effect of food on the pharmacokinetics of TAS‐102 and its efficacy and safety in patients with advanced solid tumors

Por Yoshino, Takayuki, Kojima, Takashi, Bando, Hideaki, Yamazaki, Tomoko, Naito, Yoichi, Mukai, Hirofumi, Fuse, Nozomu, Goto, Koichi, Ito, Yuko, Doi, Toshihiko, Ohtsu, Atsushi
Publicado no Cancer Sci (2016)

Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma

Por Hatogai, Ken, Kitano, Shigehisa, Fujii, Satoshi, Kojima, Takashi, Daiko, Hiroyuki, Nomura, Shogo, Yoshino, Takayuki, Ohtsu, Atsushi, Takiguchi, Yuichi, Doi, Toshihiko, Ochiai, Atsushi
Publicado no Oncotarget (2016)

Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines

Por Fukuoka, Shota, Kojima, Takashi, Koga, Yoshikatsu, Yamauchi, Mayumi, Komatsu, Masayuki, Komatsuzaki, Rie, Sasaki, Hiroki, Yasunaga, Masahiro, Matsumura, Yasuhiro, Doi, Toshihiko, Ohtsu, Atsushi
Publicado no Oncotarget (2016)